David Koelle
Internal Medicine · Seattle, WANPI 1508942350
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,833 of the $8,983 with a category attached, or 64.9%. 6 manufacturers reported payments, led by Gilead at 58.7% of the total. Reporting peaked in 2019 at $7,931 and has fallen 96.0% since, to $320 in 2024. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $272.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$5K
- GSK$2K
- Eisai Inc.$613
- ZOLL Medical Corporation$320
- Perrigo Company PLC$300
- Sentynl Therapeutics, Inc.$120
Across 1 payment — averaging $50,561 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$51K
What the payments were for
- Consulting fees$5,83365%
- Speaking & faculty fees$3003%
- Travel & lodging$2,17524%
- Food & beverage$6768%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 6 | $5,270 |
| GSK | 23 | $2,360 |
| Eisai Inc. | 1 | $613 |
| ZOLL Medical Corporation | 1 | $320 |
| Perrigo Company PLC | 1 | $300 |
| Sentynl Therapeutics, Inc. | 1 | $120 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Defibrillator$320
How this compares
$8,983 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Seattle
- Peter ShalitSeattle$1M
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Kevin ChungSeattle$35K
- David DaleSeattle$35K
- Catherine BenzigerSeattle$13K
- Christopher DoddSeattle$12K
- Dedra BuchwaldSeattle$11K
- Thao NguyenSeattle$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.